Psychedelics like psilocybin, DMT, and LSD are increasingly welcomed in behavioural and psychiatric research, with implications that extend well beyond neuroscience. This webinar will delve into efforts to transform anecdotal evidence into supported medical interventions through systematic research and controlled clinical trials.